27 related articles for article (PubMed ID: 31376196)
1. Lentiviral vector-mediated insertional mutagenesis screen identifies genes that influence androgen independent prostate cancer progression and predict clinical outcome.
Nalla AK; Williams TF; Collins CP; Rae DT; Trobridge GD
Mol Carcinog; 2016 Nov; 55(11):1761-1771. PubMed ID: 26512949
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of an ETV1 rabbit monoclonal antibody for the immunohistochemical detection of ETV1 expression in cancer tissue specimens.
Schafer C; Young D; Singh H; Jayakrishnan R; Banerjee S; Song Y; Dobi A; Petrovics G; Srivastava S; Srivastava S; Sesterhenn IA; Chesnut GT; Tan SH
J Immunol Methods; 2023 Jul; 518():113493. PubMed ID: 37196930
[TBL] [Abstract][Full Text] [Related]
3. Androgen up-regulation of Twist1 gene expression is mediated by ETV1.
Khatiwada P; Kannan A; Malla M; Dreier M; Shemshedini L
PeerJ; 2020; 8():e8921. PubMed ID: 32296610
[TBL] [Abstract][Full Text] [Related]
4. The long tail of oncogenic drivers in prostate cancer.
Armenia J; Wankowicz SAM; Liu D; Gao J; Kundra R; Reznik E; Chatila WK; Chakravarty D; Han GC; Coleman I; Montgomery B; Pritchard C; Morrissey C; Barbieri CE; Beltran H; Sboner A; Zafeiriou Z; Miranda S; Bielski CM; Penson AV; Tolonen C; Huang FW; Robinson D; Wu YM; Lonigro R; Garraway LA; Demichelis F; Kantoff PW; Taplin ME; Abida W; Taylor BS; Scher HI; Nelson PS; de Bono JS; Rubin MA; Sawyers CL; Chinnaiyan AM; ; Schultz N; Van Allen EM
Nat Genet; 2018 May; 50(5):645-651. PubMed ID: 29610475
[TBL] [Abstract][Full Text] [Related]
5. Molecular archeology: unearthing androgen-induced structural rearrangements in prostate cancer genomes.
Demichelis F; Garraway LA; Rubin MA
Cancer Cell; 2013 Feb; 23(2):133-5. PubMed ID: 23410968
[TBL] [Abstract][Full Text] [Related]
6. Construction and validation of a chromatin regulator-related gene signature for prognostic and therapeutic significance of clear cell renal cell carcinoma.
Zhang C; Zeng J; Ye C; Tian K; Xian Z
Transl Cancer Res; 2024 Jan; 13(1):150-172. PubMed ID: 38410230
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of Glycine N-Acyltransferase in Kidney Renal Clear Cell Carcinoma: A Bioinformatic-Based Screening.
Muñoz JP; Calaf GM
Diagnostics (Basel); 2023 Nov; 13(23):. PubMed ID: 38066746
[TBL] [Abstract][Full Text] [Related]
8. Decreased Expression of GLYATL1 Predicts Poor Prognosis in Patients with Clear Cell Renal Cell Carcinoma.
Deng L; Jiang H
Int J Gen Med; 2023; 16():3757-3768. PubMed ID: 37649851
[TBL] [Abstract][Full Text] [Related]
9. Comparing the Biology of Young versus Old Age Estrogen-Receptor-Positive Breast Cancer through Gene and Protein Expression Analyses.
Siddig A; Wan Abdul Rahman WF; Mohd Nafi SN; Sulong S; Yahya MM; Al-Astani Tengku Din TAD; Razali R; Musa KI
Biomedicines; 2023 Jan; 11(1):. PubMed ID: 36672708
[TBL] [Abstract][Full Text] [Related]
10. The involvement of high succinylation modification in the development of prostate cancer.
Zhang Z; Chen Y; Fang L; Zhao J; Deng S
Front Oncol; 2022; 12():1034605. PubMed ID: 36387072
[TBL] [Abstract][Full Text] [Related]
11. Identification of Ten Core Hub Genes as Potential Biomarkers and Treatment Target for Hepatoblastoma.
Sun R; Li S; Zhao K; Diao M; Li L
Front Oncol; 2021; 11():591507. PubMed ID: 33868991
[TBL] [Abstract][Full Text] [Related]
12. The expression and prognostic value of GLYATL1 and its potential role in hepatocellular carcinoma.
Guan R; Hong W; Huang J; Peng T; Zhao Z; Lin Y; Yu M; Jian Z
J Gastrointest Oncol; 2020 Dec; 11(6):1305-1321. PubMed ID: 33457003
[TBL] [Abstract][Full Text] [Related]
13. Characterization of glycine-N-acyltransferase like 1 (GLYATL1) in prostate cancer.
Eich ML; Chandrashekar DS; Rodriguez Pen A MDC; Robinson AD; Siddiqui J; Daignault-Newton S; Chakravarthi BVSK; Kunju LP; Netto GJ; Varambally S
Prostate; 2019 Oct; 79(14):1629-1639. PubMed ID: 31376196
[TBL] [Abstract][Full Text] [Related]
14. ETV1 is a novel androgen receptor-regulated gene that mediates prostate cancer cell invasion.
Cai C; Hsieh CL; Omwancha J; Zheng Z; Chen SY; Baert JL; Shemshedini L
Mol Endocrinol; 2007 Aug; 21(8):1835-46. PubMed ID: 17505060
[TBL] [Abstract][Full Text] [Related]
15. Induction of prostatic intraepithelial neoplasia and modulation of androgen receptor by ETS variant 1/ETS-related protein 81.
Shin S; Kim TD; Jin F; van Deursen JM; Dehm SM; Tindall DJ; Grande JP; Munz JM; Vasmatzis G; Janknecht R
Cancer Res; 2009 Oct; 69(20):8102-10. PubMed ID: 19789348
[TBL] [Abstract][Full Text] [Related]
16. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.
Tomlins SA; Laxman B; Dhanasekaran SM; Helgeson BE; Cao X; Morris DS; Menon A; Jing X; Cao Q; Han B; Yu J; Wang L; Montie JE; Rubin MA; Pienta KJ; Roulston D; Shah RB; Varambally S; Mehra R; Chinnaiyan AM
Nature; 2007 Aug; 448(7153):595-9. PubMed ID: 17671502
[TBL] [Abstract][Full Text] [Related]
17. ETS variant 1 regulates matrix metalloproteinase-7 transcription in LNCaP prostate cancer cells.
Shin S; Oh S; An S; Janknecht R
Oncol Rep; 2013 Jan; 29(1):306-14. PubMed ID: 23076342
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide analysis of ETV1 targets: Insights into the role of ETV1 in tumor progression.
Eid W; Abdel-Rehim W
J Cell Biochem; 2019 Jun; 120(6):8983-8991. PubMed ID: 30629294
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
